Overview

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer